Johnson And Johnson News - JNJ

Children's Self-Perceptions Improve More With Contact Lenses vs. Glasses

Three-year study of children ages 8-11 years shows contact lens wearers feel better about their Physical Appearance, Athletic Competence, and...

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today...

Beacon Equity Issues Technical Trade Alerts on Market Movers: GIS, CAKE, JNJ, ROH, PH, FAST

DALLAS, Jan. 20 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all...

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results

2008 Full-Year Sales of $63.7 Billion increased 4.3%; Full-Year EPS was $4.57 NEW BRUNSWICK, N.J., Jan. 20 /PRNewswire-FirstCall/ -- Johnson...

Court of Appeals Overturns 2005 Patent Verdict Against Cordis

WARREN, N.J., Jan. 15 /PRNewswire/ -- The Court of Appeals for the Federal Circuit in Washington, D.C. today found Boston Scientific...

Johnson & Johnson to Review Fourth-Quarter and Full-Year 2008 Financial Results

NEW BRUNSWICK, N.J., Jan. 13 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday...

Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows

Largest randomized trial of its kind shows no clinically meaningful difference between contacts and glasses for progression of nearsightedness...

Johnson & Johnson to Participate in Credit Suisse 2008 Health Care Conference

NEW BRUNSWICK, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the Credit Suisse 2008 Health Care Conference on...

Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of

- Report shows three-line average visual acuity improvement maintained at two years - SARATOGA, Calif., Nov. 5 /PRNewswire/ -- VisionCare...

Johnson & Johnson Announces Executive Appointments: Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky, Wor

NEW BRUNSWICK, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced that Sheri McCoy, currently Worldwide Chairman, Surgical...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Johnson And Johnson (JNJ)

Professional-Grade Tools, for Individual Investors.

JNJ News

Children's Self-Perceptions Improve More With Contact Lenses vs. Glasses

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

Beacon Equity Issues Technical Trade Alerts on Market Movers: GIS, CAKE, JNJ, ROH, PH, FAST

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results

Court of Appeals Overturns 2005 Patent Verdict Against Cordis

Johnson & Johnson to Review Fourth-Quarter and Full-Year 2008 Financial Results

Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows

Johnson & Johnson to Participate in Credit Suisse 2008 Health Care Conference

Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.

Vision-Related Quality of Life Benefits Improve More for Children Who Wear Contact Lenses Versus Glasses

Johnson & Johnson Reports 2008 Third-Quarter Results:

FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment

Johnson & Johnson Announces Executive Appointments: Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky, Wor

JNJ Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Johnson And Johnson (JNJ) News

Johnson And Johnson (JNJ)

Professional-Grade Tools, for Individual Investors.

JNJ News

Children's Self-Perceptions Improve More With Contact Lenses vs. Glasses

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

Beacon Equity Issues Technical Trade Alerts on Market Movers: GIS, CAKE, JNJ, ROH, PH, FAST

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results

Court of Appeals Overturns 2005 Patent Verdict Against Cordis

Johnson & Johnson to Review Fourth-Quarter and Full-Year 2008 Financial Results

Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows

Johnson & Johnson to Participate in Credit Suisse 2008 Health Care Conference

Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.

Vision-Related Quality of Life Benefits Improve More for Children Who Wear Contact Lenses Versus Glasses

Johnson & Johnson Reports 2008 Third-Quarter Results:

FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment

Johnson & Johnson Announces Executive Appointments: Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky, Wor

JNJ Discussion

Your Recent History